Financial Synergies Wealth Advisors, Inc. Abb Vie Inc. Transaction History

Financial Synergies Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$159.82 - $182.1 $39,475 - $44,978	247 Added 177.7%	386 $70.3 Million
Q4 2023 Apr 04, 2024	SELL	$137.6 - $154.97 $33,574 - $37,812	-244 Reduced 63.71%	139 $22.5 Million
Q3 2023 Apr 04, 2024	SELL	$133.59 - $154.65 $26,450 - $30,620	-198 Reduced 34.08%	383 $57.1 Million
Q2 2023 Apr 04, 2024	BUY	$132.51 - $164.9 $530 - $659	4 Added 0.69%	581 $78.2 Million
Q1 2023 Apr 04, 2024	BUY	$144.61 - $166.54 $63,339 - $72,944	438 Added 315.11%	577 $92 Million
Q4 2022 Apr 04, 2024	BUY	$138.31 - $165.87 $19,225 - $23,055	139 New	139 $22.5 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.